In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlycoMimetics Inc.

www.glycomimetics.com

Latest From GlycoMimetics Inc.

Asia Deal Watch: BeiGene Leaps Into New Year By Licensing DKK1 Antibody Candidate

BeiGene’s license agreement with Leap Therapeutics covers Asia, except for Japan, along with Australia and New Zealand. Apollomics obtains rights in China and beyond to GlycoMimetics’ e-selectin antagonists.

Deals Business Strategies

Sickle Cell Disease Market Snapshot: "The Time Has Come"

Three new drugs for sickle cell disease could be on the market in the US next year, representing a groundswell of advancement for the devastating blood disorder that has had limited options.

Blood & Coagulation Disorders Launches

Global Blood Therapeutics' Voxelotor On Track For 2020 Sickle Cell Shakeup

The company's NDA for voxelotor was accepted by the US FDA for priority review with action expected in February, setting up a showdown with Novartis.

Blood & Coagulation Disorders Drug Review

Sickle Blow For Pfizer’s Rivipansel At Phase III RESETs Expectations

After a long wait, the top-line data for Pfizer’s RESET study of the investigational treatment for sickle cell disease disappoint. Shares in rivipansel’s originator GlycoMimetics halved on the news.

Clinical Trials Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GlycoMimetics Inc.
  • Senior Management
  • Rachel K King, CEO
    Brian Hahn, SVP, CFO
    John Magnani, PhD, SVP, Research & CSO
    Armand Girard, SVP, Strategy & Corp. Dev.
    Eric Feldman, MD, VP, Clinical Dev.
  • Contact Info
  • GlycoMimetics Inc.
    Phone: (240) 243-1201
    9708 Medical Center Dr.
    Rockville, MD 20850
    USA
UsernamePublicRestriction

Register